IRIS
LIAKOULI, Vasiliki
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.866
EU - Europa 2.502
AS - Asia 2.420
SA - Sud America 645
AF - Africa 29
Totale 8.462
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.823
RU - Federazione Russa 1.132
SG - Singapore 856
IE - Irlanda 607
HK - Hong Kong 558
BR - Brasile 550
CN - Cina 519
GB - Regno Unito 238
KR - Corea 177
VN - Vietnam 161
DE - Germania 147
IT - Italia 119
GR - Grecia 113
SE - Svezia 43
AR - Argentina 37
UA - Ucraina 37
IN - India 35
ID - Indonesia 20
TR - Turchia 19
EC - Ecuador 17
BD - Bangladesh 16
CA - Canada 16
CO - Colombia 15
MX - Messico 14
JP - Giappone 13
FI - Finlandia 12
FR - Francia 12
ZA - Sudafrica 11
PY - Paraguay 10
IQ - Iraq 9
PK - Pakistan 9
NL - Olanda 8
AT - Austria 7
UZ - Uzbekistan 7
VE - Venezuela 5
BE - Belgio 4
DZ - Algeria 4
JM - Giamaica 4
KE - Kenya 4
MA - Marocco 4
PE - Perù 4
PL - Polonia 4
CL - Cile 3
CR - Costa Rica 3
EG - Egitto 3
KZ - Kazakistan 3
NP - Nepal 3
SA - Arabia Saudita 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
IL - Israele 2
JO - Giordania 2
LV - Lettonia 2
PT - Portogallo 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BZ - Belize 1
ES - Italia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 8.462
Salva come PNG Salva come JPEG
Città #
Dublin 607
Hong Kong 554
Chicago 534
Santa Clara 470
Wilmington 441
Moscow 345
Falls Church 338
Singapore 327
Jacksonville 177
Seoul 175
Princeton 110
Roxbury 108
Chandler 103
Bremen 102
Beijing 94
Medford 75
Hefei 67
Ho Chi Minh City 65
Des Moines 41
Hanoi 36
Cambridge 35
São Paulo 35
Ashburn 32
Dallas 25
Naples 23
Rome 23
Bengaluru 19
The Dalles 19
Rio de Janeiro 17
Nanjing 14
New York 14
Belo Horizonte 13
Guangzhou 13
Ann Arbor 12
Jinan 12
Curitiba 11
Guarulhos 11
Brasília 10
Caserta 9
Los Angeles 9
Amsterdam 8
Hangzhou 8
Hebei 8
Munich 8
Ottawa 8
Shenyang 8
Tianjin 8
Boardman 7
Ningbo 7
Salvador 7
Tashkent 7
Baghdad 6
Changsha 6
Frankfurt am Main 6
Hải Dương 6
Johannesburg 6
Kunming 6
Santo André 6
Shanghai 6
Thái Bình 6
Athens 5
Bagnoli Irpino 5
Biên Hòa 5
Campinas 5
Caxias do Sul 5
Dearborn 5
Falkenstein 5
Guayaquil 5
Lấp Vò 5
Marsico Nuovo 5
Ribeirão Preto 5
Woodbridge 5
Afragola 4
Aparecida de Goiânia 4
Asunción 4
Bogotá 4
Brussels 4
Ciudad del Este 4
Contagem 4
Da Nang 4
Fortaleza 4
Haiphong 4
Helsinki 4
Hortolândia 4
Itabira 4
Kingston 4
Kostroma 4
Lahore 4
Mugnano di Napoli 4
Nairobi 4
Natal 4
Nuremberg 4
Praia Grande 4
San Mateo 4
Seattle 4
Suzano 4
Taizhou 4
Vienna 4
Barbacena 3
Bauru 3
Totale 5.433
Salva come PNG Salva come JPEG
Nome #
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 1.349
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 132
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 106
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population 101
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 89
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 89
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 84
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 81
AB0226 Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC). 81
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 80
AB0244 Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) 80
. FRI0437 Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from SSC Patients Induces an Anti Angiogenetic Effect, when Co-Cultured with Endothelial Cells. 79
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 79
Association of FASG670A gene polymorphism with systemic sclerosis. 78
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 78
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 77
Angiogenic cytokines and growth factors in systemic sclerosis 77
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 76
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome 74
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 74
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 71
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 70
Interstitial lung disease in systemic sclerosis: current and future treatment 70
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 68
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 68
Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? 68
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 67
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset 66
Modificazioni della nitrossido-sintasi neuronale (nNOS) nella cute dei pazienti con sclerosi sistemica (SSc). 65
IMPAIREMENT OF ENDOTHELIAL DIFFERENTIATION FROM MESENCHYMAL STEM CELLS (MSC) IN SYSTEMIC SCLEROSIS (SSC): A NEW TOOL IN PATHOGENETIC MECHANISM 65
Interleukin-33 and its receptor st2 may serve as 'alarmin' system of the progressing damage to the skin and visceral organs of systemic sclerosis (ssc) patients 65
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 64
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 64
Cardiovascular disease in primary sjögren’s syndrome 64
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 64
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 64
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS 63
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 63
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 62
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease. 62
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 61
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 61
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 60
AB0248 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 60
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION 60
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies 59
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 59
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 59
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI) 59
Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage 59
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease 58
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 58
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 58
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implication. 58
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis 58
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 58
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 56
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 56
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 56
SAT0191 Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren's syndrome. 56
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine 56
Macitentan inhibits the transforming growth factor-βprofibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts. 56
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy 55
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 55
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 55
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 54
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients 54
SDF-1 expression in the skin of SSc patients. 54
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 54
Methotrexate: an old new drug in autoimmune disease 54
Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma 54
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 53
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 53
Subclinical and clinical atherosclerosis in rheumatoid arthritis: Results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 53
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 53
Cellular players in angiogenesis during the course of systemic sclerosis 52
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 52
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) 52
FAS -670 gene promoter polymorphism confers susceptibility to systemic sclerosis 52
Decreased expression of angiopoietin 1 on perivascular mesenchymalstemcells from SSc patients induces an anti angiogenic effect, when co-cultured with endothelial cells 52
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor 52
Tocilizumab for the treatment of adult-onset Still's disease: results from a case series 52
Studio dell’espressione della chemochina SDF-1 e del suo recettore CXCR4 nella cute e nelle cellule endoteliali microvascolari di pazienti affetti da sclerosi sistemica (SSc). 51
The Vessels Contribute to Fibrosis in Systemic Sclerosis 51
Potential of stem cells in the treatment of rheumatic didease 51
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 51
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 51
Towards a consensus on the clinical applications and interpretations of the nailfold capillaroscopy standards in clinical practice: An initiative by the Egyptian Society of Microcirculation 50
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 50
Use of Rituximab in the Management of Sjögren’s Syndrome 50
Endothelial Progenitor Cells (EPC) characterization in systemic sclerosis (SSc) patients. 50
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 49
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 49
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 49
Pigment epithelium derived factor secreted by ssc fibroblasts inhibits angio and vasculogenesis in vitro. 48
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features 47
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study 46
Mesenchymal stem cells transplantation in Systemic Sclerosis: comment on the article by ATJ Maria et al 46
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients 46
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 46
Totale 7.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021248 0 0 0 0 0 2 105 10 12 8 109 2
2021/20221.446 73 133 258 115 322 30 24 25 43 30 84 309
2022/20231.336 206 85 308 14 138 37 0 27 503 2 5 11
2023/2024356 18 9 3 7 160 10 6 12 4 7 9 111
2024/20251.826 1 0 3 31 240 283 292 165 231 395 111 74
2025/20263.007 258 343 425 482 652 847 0 0 0 0 0 0
Totale 8.683